News about "Pharma IPO"

Rubicon Research to Launch IPO on 9 October; Price Band Set at INR 461- INR 485 Per Share

Rubicon Research to Launch IPO on 9 October; Price Band Set at INR 461- INR 485 Per Share

Rubicon Research Limited has announced the launch of its initial public offering (IPO) of equity shares with a face value of ?1 each, opening on 9 October 2025. The Anchor Investor bidding date is set for 8 October 2025, while the offer will close on 13 October 2025.
<br />

Pharma IPO | 07/10/2025 | By Darshana

Stada Eyes Autumn IPO as Sale Talks Stall and Market Conditions Improve

Stada Eyes Autumn IPO as Sale Talks Stall and Market Conditions Improve

Stada and its owners are also considering alternative ownership options, including a potential sale. The company previously held talks with private equity firm CapVest, which would have valued Stada at around 10 billion euro including debt. Those discussions have since stalled, prompting a stronger push toward the IPO route.

Pharma IPO | 29/08/2025 | By Darshana


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members